lifestyle.californiaconsumerbanking.com

Author: Aspire Biopharma Holdings, Inc.

Aspire Biopharma’s Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

May 2, 2026
Aspire Biopharma’s Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

May 2, 2026
Aspire Biopharma’s Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

May 1, 2026
Aspire Biopharma’s BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

May 1, 2026
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

April 29, 2026
Aspire Biopharma’s Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

April 29, 2026
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements

March 11, 2026
Aspire Biopharma’s Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record

March 11, 2026
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

March 10, 2026
Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors

March 10, 2026